![Jeffery F. Miller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffery F. Miller
Founder at Pylum Biosciences, Inc.
Jeffery F. Miller active positions
Companies | Position | Start | End |
---|---|---|---|
David Geffen School of Medicine | Corporate Officer/Principal | - | - |
Pylum Biosciences, Inc.
![]() Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Director/Board Member | - | - |
Founder | - | - |
Career history of Jeffery F. Miller
Former positions of Jeffery F. Miller
Companies | Position | Start | End |
---|---|---|---|
AvidBiotics Corp.
![]() AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Director/Board Member | 31/12/2004 | - |
Founder | 31/12/2004 | - |
Training of Jeffery F. Miller
Tufts University School of Medicine | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Director/Board Member | 2 |
Founder | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
AvidBiotics Corp.
![]() AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Health Technology |
Pylum Biosciences, Inc.
![]() Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Jeffery F. Miller
- Experience